Evaluating a deep learning AI algorithm for detecting residual prostate cancer on MRI after focal therapy

• David G. Gelikman,
• Stephanie A. Harmon,
• Alexander P. Kenigsberg,
• Yan Mee Law,
• Enis C. Yilmaz,
• Maria J. Merino,
• Bradford J. Wood,
• Peter L. Choyke,
• Peter A. Pinto,
• Baris Turkbey

Affiliations

David G. Gelikman

Molecular Imaging Branch, National Cancer Institute National Institutes of Health Bethesda Maryland USA

Stephanie A. Harmon

Molecular Imaging Branch, National Cancer Institute National Institutes of Health Bethesda Maryland USA

Alexander P. Kenigsberg

Urologic Oncology Branch, National Cancer Institute National Institutes of Health Bethesda Maryland USA

Yan Mee Law

Department of Radiology Singapore General Hospital Singapore

Enis C. Yilmaz

Molecular Imaging Branch, National Cancer Institute National Institutes of Health Bethesda Maryland USA

Maria J. Merino

Laboratory of Pathology, National Cancer Institute National Institutes of Health Bethesda Maryland USA

Bradford J. Wood

Center for Interventional Oncology, National Cancer Institute National Institutes of Health Bethesda Maryland USA

Peter L. Choyke

Molecular Imaging Branch, National Cancer Institute National Institutes of Health Bethesda Maryland USA

Peter A. Pinto

Urologic Oncology Branch, National Cancer Institute National Institutes of Health Bethesda Maryland USA

Baris Turkbey

Molecular Imaging Branch, National Cancer Institute National Institutes of Health Bethesda Maryland USA